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Abstract
Purpose To evaluate the safety and efficacy of prophy-
lactic uterine artery embolization (UAE)-assisted cesarean
section for the prevention of intrapartum hemorrhage.
Materials and Methods Twelve consecutive pregnant
women (mean age 31 years; range 25–38) with uterine
scarring and placenta previa and/or placenta accreta
underwent UAE in conjunction with cesarean section to
prevent intrapartum hemorrhage. For UAE, the left uterine
artery was catheterized prophylactically under fluoroscopic
guidance before the cesarean section incision was made.
After the infant had been delivered, bilateral UAE was
performed with the placenta still in situ. After successful
bilateral UAE, the placenta was detached from the uterine
wall.
Results Technical success was achieved in all 12 cases.
Ten patients retained their uterus, and the other 2 under-
went hysterectomy. The mean operative blood loss was
1,391 mL (range 600–3,600 mL). The total mean fluoros-
copy time and mean absorbed dose (air kerma) were 9 min
40 s (range 4 min 35 s–15 min 24 s) and 91.79 mGy
(range 30.2–171), respectively. The average fetal fluoros-
copy time was 1 min 42 s (range 41 s to 3 min 16 s) with
an average X-ray dose of 17.66 mGy (range 6.04–23.90).
Conclusion UAE-assisted cesarean section is safe and
effective in the prevention of intrapartum hemorrhage in
patients with uterine scarring and/or placental
abnormalities.
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Introduction
Abnormal placentation, which broadly comprises placenta
previa, accreta, increta, and percreta, is a leading cause of
massive peripartum hemorrhage [1]. It frequently leads to
emergency hysterectomies, surgical manipulation of organs
adjacent to the uterus (ureter and bladder), respiratory
distress syndrome, kidney failure, and even death [2, 3].
Blood loss in cesarean sections among patients with pla-
cental accreta can vary from 3,000 to 5,000 mL [4]. These
conditions have been associated with significant maternal
morbidity and mortality, and their occurrence has been
reported to be increasing in recent decades [1, 5, 6].
Recently prophylactic hypogastric artery occlusion has
been introduced to decrease intraoperative blood loss in
patients at high risk for peripartum hemorrhage [4, 7]. The
procedure consists of bilateral placement of embolizing
materials and/or balloon catheters by way of the femoral
arteries under fluoroscopic guidance. The literature offers
evidence on the utility of preoperative placement of
hypogastric artery catheters in decreasing blood loss and
improving surgical outcomes [4, 7]. However, radiation
exposure to the fetus and uterus during preoperative
placement of balloon catheters or angiocatheters remains
controversial. In addition, detailed data on fetal radiation
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exposure and maternal radiation exposure to the uterus
have not been reported. Furthermore, transfer of the patient
from the angiography suite to an operating room after
prophylactic catheter placement will increase the com-
plexity and risk of the procedure, particularly in unstable
patients [8].
In this study, we investigated the safety and efficacy of
uterine artery embolization (UAE) with preoperative
catheterization in the unilateral uterine artery for assisted
cesarean section for preventing intrapartum hemorrhage in
patients with uterine scarring and/or placental abnormali-
ties. The fetal and maternal radiation exposure doses were
also recorded and analyzed.
Materials and Methods
Our Institutional Review Board approved this study.
Between February 2012 and 2013, the patient cohort con-
sisted of 12 parturients ranging in age from 25 to 38 years
(mean 31) who had placental accreta and/or placenta previa
on ultrasonic Doppler and/or magnetic resonance imaging
during the prenatal period. All patients had a history of at
least one previous cesarean section. Their average number
of previous pregnancies was 3.6 (range 2 to 8). All indi-
viduals had a clinical diagnosis of a potential high risk for
massive intrapartum hemorrhage because of the abnormal
placenta; the average gestational duration was 36 weeks
(range 31 to 39; Table 1).
Before surgery, all patients provided written informed
consent and were brought to a regular operating room fitted
with a moveable C-arm equipped with digital subtraction
angiography (DSA; Philips Medical Systems, Best, Neth-
erlands) and a conventional operating table. After anes-
thetizing the patient with an epidural block, preoperative
placement of temporary bilateral ureteral stents under
cystoscopy and vesical catheter insertion were performed.
In each patient, a 5F sheath was placed in the right com-
mon femoral artery using Seldinger technique. Selective
catheterization of the left uterine artery was performed with
a 5F Roberts uterine curve (RUC) catheter (Cook,
Bloomington, IN) under fluoroscopic guidance. The
cumulative radiation dose and fluoroscopy time during the
selective catheterization of the left uterine artery were
recorded with the fetus in situ. The cumulative radiation
dose absorbed per patient (air kerma) was recorded using
the DSA system during fluoroscopy. Then a traditional
cesarean delivery procedure was performed. After the
infant had been delivered and the umbilical cord clamped,
the obstetrician clipped any bleeding vessels using hemo-
static forceps and packed the vagina and the uterus with the
placenta still in situ (Fig. 1).
Under fluoroscopic guidance, the left uterine artery was
embolized first, following which the right uterine artery was
selectively catheterized and embolized with Gelform sponge
pledgets (absorbable gelform sponge; Jinling pharmaceutical
company, Nanjing, China) mixed with contrast medium.
Both uterine arteries were embolized until there was ade-
quate stasis, and the catheter and sheath were kept stationary
in case further embolization was necessary. The cumulative
radiation dose and fluoroscopy time during bilateral UAE
were recorded, and the complete placenta was removed
manually from the uterine wall using the traditional cae-
sarean section technique. If bleeding continued even after
bilateral UAE and led to an unstable blood pressure, emer-
gency hysterectomy was performed.
After closing the uterine lumen and abdominal cavity
and observing no vaginal bleeding, the angiocatheter was
removed under fluoroscopic guidance. The puncture point
of the right femoral artery was compressed for more than











MRI or US findings
1/30 36 4 1 Placenta accreta and placenta previa
2/38 35?5 8 1 Placenta percreta and placenta previa
3/35 35?2 3 1 Placenta previa
4/31 33?2 3 1 Placenta accreta and placenta previa
5/33 35?1 3 1 Placenta previa
6/31 35?2 2 1 Placenta accreta and placenta previa
7/35 33 8 1 Placenta accreta and placenta previa
8/33 34?1 3 1 Placenta previa
9/26 35?5 4 1 Placenta accreta and placenta previa
10/30 35 7 1 Placenta accreta and placenta previa
11/27 39?5 2 1 Placenta previa
12/27 31?2 3 1 Placenta accreta and placenta previa
Mean/31.3 35?2 4 1 –
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10 min for hemostasis. Intraoperative blood loss and vol-
umes administered to the patient (crystalloid, colloid, and
blood) were recorded. The length of surgery, infants’ Ap-
gar scores, and any complications after the procedure were
recorded.
Results
No fetal or maternal mortality occurred in this group. Two
parturients had refractory postpartum hemorrhage that was
controlled by bilateral UAE followed by hysterectomy. The
first of these patients had a large placenta previa that even
covered the cervical os, and the second patient had placenta
percreta, which extended into the uterine serosa and the
wall of bladder. In 11 of 12 cases, the infant’s Apgar score
was 8 to 10 at 1 and 5 min, respectively; the remaining
neonate scored 5 at birth, but the score increased to 8 at
5 min after cardiopulmonary resuscitation. In 7 of 12 cases,
the average fluoroscopy time used to place the RUC
catheter was 1 min 42 s (range 41 s to 3 min 16 s). The
average X-ray dose was 17.66 mGy (range 6.04–23.90),
and the average dose area product was 0.493 mGym2
(range 0.174–0.709). For the first five cases, we only
recorded total fluoroscopy time and dose. The average total
duration of fluoroscopy was 9 min 40 s (range 4 min 35 s
to 15 min 24 s). The average dose was 91.79 mGy (range
30.2–71), and the average dose area product was 2.37
mGym2 (range 0.849–4.09).
The average blood loss during the surgical procedure of
all 12 cases was 1,391 mL (range 600–3,600), and the
average urinary amount was 358 mL (range 200–500). The
average volume of liquids administered was 2,333 mL
(range 800–7,000). The average volume of colloid
administered was 393 mL (range 200 to 910), and the
average amount of blood transfused was 4.875 units (range
2 to 13) of packed red blood cells. The average duration of
the surgical procedure was 2 h 19 min (range 1 h 20 min to
3 h 30 min; Table 2). No further complications, such as
infection and hemorrhage, were found in any of the cases.
All patients had normal pulsation in the dorsal artery of the
foot. The volume of vaginal bleeding was approximately
80 mL (range 20–150). The mean postoperative hospital-
ization time was 8.75 days (range 7–10). The documenta-
tion for every patient was complete.
Discussion
In this study, we showed that UAE-assisted cesarean sec-
tion is an effective and safe method that is useful in the
prevention of massive intrapartum hemorrhage in patients
with abnormal placenta. In 10 of 12 patients, the uterus
were successfully preserved with complete placental
removal after prophylactic bilateral UAE.
Previous studies on conventional hysterectomy in simi-
lar patients found massive blood loss [9, 10]. Eller et al.
identified 76 cases of patients with placenta accreta who
underwent hysterectomy and reported that mean blood loss
was *2.6 L [11]. Compared with those reports, there was
much less blood loss (average 1,391 mL) in our study.
Weeks et al. [4] reviewed 21 patients undergoing hys-
terectomy who also underwent perioperative temporary
balloon iliac artery occlusion. Although balloon occlusion
Fig. 1 Fluoroscopy images during procedure: Steps of prophylactic
UAE-assisted cesarean section procedure in a 26-year-old patient
(case no. 9). A A uterine catheter was inserted into the left uterine
artery (arrow) superselectively before delivery. The fetus (arrow-
head) is located within the uterus. B The left uterine artery (arrow)
can be seen after successful embolization with ample gelfoam and
contrast medium deposition. In addition, note the multiple shadows of
hemostats used to stop bleeding after delivery. The placental outline
can also be seen because it was still attached to the uterine wall.
C The right uterine artery (arrow) can be seen after selective
catheterization and embolization after infant delivery and before
placental separation






































































































































































































































































































































































































































































































































































































































































































































































































































Q. Li et al.: Prophylactic UAE-Assisted Cesarean Section 1461
123
was performed before hysterectomy, there was still an
estimated blood loss of 1,671.5 mL. Another report
employing similar methods reported estimated blood losses
in successful cases ranging from 500 to 2,300 mL [8],
which is similar to our study. However, in the same study,
there were 6 cases (54 %) with the placenta left in situ,
which might have led to a high incidence of recidivism.
There was also massive blood loss in the two failed cases
(13,000 and 10,000 mL). The timing of insertion of the
RUC catheter—after delivery of the baby in that study [8]
compared with before delivery in our study—is the primary
difference between the two reports. Delayed RUC insertion
after delivery of the baby can lead to a delay in emboli-
zation, which could explain the higher volume of post-
partum hemorrhage.
We found that fetal radiation exposure was minimal
because only a single unilateral uterine artery was cathe-
terized selectively under fluoroscopic guidance while the
fetus was in utero. According to the National Council on
Radiation Protection and Measurements, the risk to an
infant from fluoroscopy dosage is increased significantly
when the radiation exposure exceeds 150 mGy [12, 13].
However, at doses of \50 mGy, the risk of radiation-
induced abnormality is considered negligible compared
with baseline risks for all developmental abnormalities,
e.g., 1 % for mental retardation and 3 % for spontaneous
birth defects [12, 14]. There was a wide range of total
radiation dose and time because in some cases secondary
UAE or other pelvic artery embolizations were performed
when the obstetrician found further intraoperative hemor-
rhage during placental separation. It was convenient and
flexible for us to perform repeat embolization because the
DSA machine was stationed in the regular operating suite
and the catheterization had been preserved.
Major complications associated with UAE in obstetric
patients occur rarely with an overall complication rate of
*9 % [8]. These include transient fever, pelvic pain,
transient foot ischemia, transient menelipsis, and abscess.
In our study, all mothers had normal pulsation of the dorsal
artery of the foot, and the average volume of vaginal
bleeding was only *80 mL. The mean hospitalization time
was 8.75 days. Compared with a perioperative temporary
occlusion study, which reported thrombogenesis in the
femoral artery and other complications [4], our method
seems to be much safer.
Another important innovation of our study was the
timing of RUC insertion into the uterine artery. Some
previous investigators did not use fluoroscopy before fetal
delivery. Instead, they inserted a 5F femoral arterial sheath
[8, 15] before delivery to minimize fetal radiation. How-
ever, the main causes of UAE failure in these studies were
vascular spasm with shock resulting from massive blood
loss along with uterine artery movements during delivery,
which made it difficult to accurately place the RUC into the
uterine artery. Although our method of placing the RUC
before delivery is simple and safe, we still must consider
the decreased blood flow associated with fetal distress and
the increased fluoroscopy exposure time if the RUC is
placed in both uterine arteries. Hence, we elected to cath-
eterize one unilateral uterine artery only before delivery to
decrease the exposure time, and the Apgar score of all but
one of the delivered fetuses was within the normal range.
A major limitation of our research was that it was ret-
rospective in nature and the fetal fluoroscopy dose was
only available for seven cases. Furthermore, this method
must be validated by prospective controlled studies before
mainstream implementation. Although we showed that
there was minimal radiation exposure to the fetus during
the positioning of the uterine artery RUC, which is below
the specific threshold radiation level for teratogenesis,
carcinogenesis is a stochastic effect of radiation, and there
is no threshold level below which the risk of cancer can be
eliminated completely [8, 12]. Hence, the safety of this
method remains to be established by long-term studies.
In recent years, there has been significant interest in the
potential role of interventional techniques in obstetrics,
specifically in the control of peripartum hemorrhage [16].
Great attention has been paid to the potential of these
procedures in improving maternal outcomes by decreasing
morbidity and mortality. In our study, the blood loss vol-
ume was effectively controlled in most cases with an
acceptable fluoroscopy dose. However, future randomized
controlled trials and long-time follow-up studies are nee-
ded to determine whether the potential benefits of UAE
during delivery outweigh the potential risks associated with
fetal radiation exposure and vascular complications.
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